Last week tech-enabled health assessment company Q Bio emerged out of stealth mode and announced a $40 million in Series B funding. Andreessen Horowitz led the round with participation from Vinod Khosla of Khosla Ventures.
Following their investments, Andreessen Horowitz’s Vijay Pande and Khosla will be joining the board.
WHAT THEY DO
The company conducts a full workup of patients based on...
